Logo
x

Search category

Subscribe Now

Initiation

Merck and Ridgeback Report the Initiation of EMA Rolling Review of Molnupiravir for the Treatment of COVID-19

Merck and Ridgeback Report the Initiation of EMA Rolling Review of Molnupiravir for the Treatment of COVID-19

  • October 25, 2021
Merck and Ridgeback Report the Initiation of EMA Rolling Review of Molnupiravir for the Treatment of COVID-19

Merck and Ridgeback Report the Initiation of EMA Rolling Review of Molnupiravir for the Treatment of COVID-19

  • October 25, 2021
PharmaShots Interview: Rain Therapeutic's Avanish Vellanki Shares Insight on the Initiation of P-III MANTRA Trial of Milademetan for Dedifferentiated Liposarcoma

PharmaShots Interview: Rain Therapeutic's Avanish Vellanki Shares Insight on the Initiation of P-III MANTRA Trial of Milademetan f...

  • August 23, 2021
PharmaShots Interview: Rain Therapeutic's Avanish Vellanki Shares Insight on the Initiation of P-III MANTRA Trial of Milademetan for Dedifferentiated Liposarcoma

PharmaShots Interview: Rain Therapeutic's Avanish Vellanki Shares Insight on the Initiation of P-III MANTRA Trial of Milademetan f...

  • August 23, 2021
Bio-Thera Reports the Initiation of P-III Clinical Trial for BAT2506 (biosimilar- golimumab)

Bio-Thera Reports the Initiation of P-III Clinical Trial for BAT2506 (biosimilar- golimumab)

  • June 9, 2021
Bio-Thera Reports the Initiation of P-III Clinical Trial for BAT2506 (biosimilar- golimumab)

Bio-Thera Reports the Initiation of P-III Clinical Trial for BAT2506 (biosimilar- golimumab)

  • June 9, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2023 PharmaShots - All Rights Reserved.